IRIS
BATTAGLINI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.684
EU - Europa 5.143
AS - Asia 2.631
SA - Sud America 544
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 15.067
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.622
GB - Regno Unito 1.475
CN - Cina 969
RU - Federazione Russa 944
SG - Singapore 852
IE - Irlanda 651
IT - Italia 588
BR - Brasile 470
UA - Ucraina 348
SE - Svezia 337
HK - Hong Kong 254
DE - Germania 239
FR - Francia 232
KR - Corea 176
VN - Vietnam 145
FI - Finlandia 120
IN - India 52
ES - Italia 47
NL - Olanda 40
TR - Turchia 38
AR - Argentina 33
MX - Messico 25
BD - Bangladesh 24
BE - Belgio 24
CA - Canada 24
ZA - Sudafrica 19
AT - Austria 14
IR - Iran 14
PL - Polonia 14
EC - Ecuador 13
MK - Macedonia 13
PK - Pakistan 13
JP - Giappone 12
PH - Filippine 11
IQ - Iraq 10
CH - Svizzera 9
CO - Colombia 9
ID - Indonesia 9
CZ - Repubblica Ceca 8
MA - Marocco 8
SA - Arabia Saudita 8
RO - Romania 7
UZ - Uzbekistan 7
CI - Costa d'Avorio 6
EG - Egitto 6
EU - Europa 6
KE - Kenya 6
RS - Serbia 6
VE - Venezuela 6
GR - Grecia 5
IL - Israele 5
JM - Giamaica 5
JO - Giordania 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CL - Cile 4
HU - Ungheria 4
KZ - Kazakistan 4
LT - Lituania 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
BN - Brunei Darussalam 3
MD - Moldavia 3
TN - Tunisia 3
BO - Bolivia 2
DZ - Algeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CU - Cuba 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
IS - Islanda 1
KG - Kirghizistan 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 15.067
Salva come PNG Salva come JPEG
Città #
Southend 1.322
Dallas 794
Fairfield 791
Dublin 646
Houston 571
Singapore 448
Ashburn 434
Woodbridge 413
Chandler 357
Santa Clara 350
Seattle 312
Wilmington 305
Jacksonville 283
Cambridge 276
Beijing 263
Moscow 259
Hong Kong 246
Hefei 191
Menlo Park 184
Seoul 176
Ann Arbor 162
Princeton 128
Siena 123
Nanjing 110
Los Angeles 72
Milan 63
The Dalles 63
Boardman 48
San Mateo 46
Helsinki 43
São Paulo 41
Dong Ket 37
Málaga 35
Buffalo 34
Ho Chi Minh City 34
Nanchang 34
New York 34
Florence 33
Columbus 32
Hanoi 31
Shenyang 31
San Diego 30
Council Bluffs 29
Pisa 25
Bengaluru 24
Rome 24
Munich 23
London 21
Brussels 20
Lancaster 20
Norwalk 19
San Francisco 19
Nuremberg 18
Redondo Beach 17
Tianjin 16
Dearborn 14
Hebei 14
Jiaxing 14
Kunming 14
Phoenix 14
Rio de Janeiro 14
Vicopisano 14
Brasília 13
Changsha 13
Jinan 13
Boston 12
Düsseldorf 12
Lappeenranta 12
Stockholm 12
Warsaw 12
Chicago 11
Izmir 11
Turku 11
Fremont 10
Genoa 10
Guarulhos 10
Poplar 10
Tokyo 10
Belo Horizonte 9
Frankfurt am Main 9
Mexico City 9
Naples 9
Sarzana 9
Shanghai 9
Brooklyn 8
Hangzhou 8
Johannesburg 8
Kilburn 8
Livorno 8
Orem 8
Atlanta 7
Carlentini 7
Chennai 7
Denver 7
Falkenstein 7
Ningbo 7
Porto Alegre 7
Toronto 7
Turin 7
Abidjan 6
Totale 10.611
Salva come PNG Salva come JPEG
Nome #
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis 443
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes 283
The role of dentate nuclei in human oculomotor control: Insights from cerebrotendinous xanthomatosis 266
[(11)C]PBR28 or [(18)F]PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis 257
SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI 257
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 251
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 250
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 241
Automated identification of brain new lesions in multiple sclerosis using subtraction images 238
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities 237
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis 230
Evidence of diffuse damage in frontal and occipital cortex in the brain of patients with post-traumatic stress disorder 228
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis 226
The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression 226
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis 225
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 224
Acute metabolic brain changes following traumatic brain injury and their relevance to clinical severity and outcome. 223
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 223
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome 222
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability 219
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. 218
Cortical lesions in radiologically isolated syndrome. 216
Long-term assessment of no evidence of disease activity in relapsing-remitting MS 213
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis 212
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI 210
Brain atrophy assessment in multiple sclerosis: importance and limitations 207
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis 204
Early structural changes in individuals at risk of familial Alzheimer's disease. A volumetry and magnetization transfer MR imaging study 203
Progression of regional grey matter atrophy in multiple sclerosis 202
Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts 194
Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. 192
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients 190
Magnetization Transfer Imaging Demonstrates a Distributed Pattern of Microstructural Changes of the Cerebral Cortex in Amyotrophic Lateral Sclerosis 188
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI 183
null 182
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis 180
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. 180
Deep gray matter volume loss drives disability worsening in multiple sclerosis 179
Topiramate effects on plasma serotonin levels in children with epilepsy 179
Diffuse structural and metabolic brain changes in Fabry disease 176
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 176
The dilemma of benign multiple sclerosis: Can we predict the risk of losing the “benign status”? A 12-year follow-up study 171
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 169
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 169
Brain MRI atrophy quantification in MS: From methods to clinical application 167
Evaluating and reducing the impact of white matter lesions on brain volume measurements 165
Lifespan normative data on rates of brain volume changes 164
Cortical functional reorganisation and its relationship with brain structural damage in patients with benign multiple sclerosis 164
T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis 163
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization 163
MRI correlates of disability in african-americans with multiple sclerosis 159
Measuring Brain Atrophy in Multiple Sclerosis 159
Association of brain atrophy with disease progression independent of relapse activity in patients with relapsing multiple sclerosis 158
Modelling the distribution of cortical lesions in multiple sclerosis 156
Automated lesion segmentation with BIANCA: Impact of population-level features, classification algorithm and locally adaptive thresholding 156
Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study. 154
Response to the letter “Progression of gray matter atrophy and its association with white matter lesions in relapsing–remitting multiple sclerosis” by Bendfeldt et al. 152
Enhanced brain extraction improves the accuracy of brain atrophy estimation. 146
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis 145
Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis 144
Structural and Metabolic Brain Abnormalities in Preclinical Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarct and Leukoencephalopathy 142
MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice 139
Mapping the progressive treatment-related reduction of Active MRI lesions in multiple sclerosis 136
Hippocampal atrophy and white matter lesions characteristics can predict evolution to dementia in patients with vascular mild cognitive impairment 134
Magnetization Transfer MR Imaging Demonstrates Degeneration of the Subcortical and Cortical Gray Matter in Huntington Disease 130
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis 129
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 121
Vitamin D levels in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 118
Clinically relevant profiles of myelin content changes in patients with multiple sclerosis: a multimodal and multicompartment imaging study 116
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course 116
Short-Term Combination of Glatiramer Acetate with IV Steroid Treatment Preceding Treatment with GA Alone Is Associated with early Suppression of MRI-disease activity in Patients with Relapsing Remitting Multiple Sclerosis 114
MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies 114
BIANCA (Brain Intensity AbNormality Classification Algorithm): a new tool for automated segmentation of white matter hyperintensities 113
null 108
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis 100
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets 99
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 98
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 97
BIANCA-MS: An optimized tool for automated multiple sclerosis lesion segmentation 95
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis 94
Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta-1a 92
The spatio-temporal relationship between white matter lesion volume changes and brain atrophy in clinically isolated syndrome and early multiple sclerosis 89
Evaluation of cervical spinal cord atrophy using a modified SIENA approach 84
Dynamic imaging of individual remyelination profiles in multiple sclerosis 76
Hippocampal atrophy in vascular MCI as biomarker of subclinical memory impairment 75
Quantification of [11C]PIB PET for imaging myelin in the human brain: A test-retest reproducibility study in high-resolution research tomography 72
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of worsening disability in multiple sclerosis 71
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 66
Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis 65
Disease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes 57
Guiding differentiation of non-acute MOGAD from AQP4-NMOSD and RRMS using clinical and MRI measures 50
Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis 50
Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a 21
Totale 15.258
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.229
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.202 0 0 0 0 0 172 160 271 148 181 142 128
2021/20221.103 82 128 89 93 54 45 71 35 62 95 149 200
2022/20231.394 80 100 158 181 146 233 42 164 157 54 45 34
2023/2024914 48 30 65 34 24 235 357 29 4 13 7 68
2024/20252.595 82 117 183 116 343 148 126 201 221 145 246 667
2025/20263.449 487 796 682 598 837 49 0 0 0 0 0 0
Totale 15.258